{"schema_version":"secwatch.filing_event.v1","accession":"0001093557-25-000111","form_type":"8-K","ticker":"DXCM","cik":"0001093557","company_name":"DEXCOM INC","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.488940+00:00","generated_at":"2026-05-22T23:42:15.795975+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"DexCom Q1 revenue $1.04B (+12% YoY); guides FY25 gross margin ~62% (down); announces $750M buyback","bullets":["GAAP net income $105.4M ($0.27 diluted EPS) vs $146.4M ($0.36) YoY; non-GAAP EPS $0.32 flat.","Revenue $1.036B (+12% reported, +14% organic); US +15%, intl +7% (organic +12%).","FY25 guidance: revenue $4.6B (+14%), non-GAAP gross margin ~62% (cut from prior), op margin ~21%, EBITDA margin ~30%.","Board authorized $750M share repurchase program through June 30, 2026.","Post-quarter FDA clearance for G7 15-day system; expanded PBM coverage and Stelo on Amazon."],"urls":{"canonical":"https://secwatch.observer/filing/0001093557-25-000111","json":"https://secwatch.observer/filing/0001093557-25-000111.json","markdown":"https://secwatch.observer/filing/0001093557-25-000111.md","text":"https://secwatch.observer/filing/0001093557-25-000111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000111/0001093557-25-000111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000111/dxcm-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T23:42:15.795975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}